study of the effectiveness of supervised vs. non-supervised therapeutic exercise in cancer patients

Conditions: Breast Cancer; Colon Cancer

Summary: aim:to evaluate the effectiveness of a therapeutic exercise program (pet) in cancer patients in improving the quality of life and the need for supervision by health professionals during the performance of same after 6 weeks of intervention. design: randomized and controlled clinical trial, parallel groups with active control group. with masking of randomization, patient evaluation and analysis of the data. subjets of study: 58 patients diagnosed with breast and colon cancer and treated up to 2 years later, both with surgery, chemotherapy and hormonal treatments (inhibitors of aromatase, tamoxifen). intervention: both groups the treatment will be a common work-based therapeutic exercise program aerobic, strength-resistance and self-stretching, in addition to a reinforcement in recommendations usual self-care. the study includes two phases, phase of supervised work and phase of tracing. one of the groups will be supervised in the realization of pet for a period of 6weeks and the other group will do it autonomously and without supervision. the patients will be followed for 1 year, with five blind evaluations: at the beginning of the study, after 6 weeks of intervention, 3, 6 and 12 months after the start of the study.measurements: principal: quality of life assessed with the questionnaire measured with the european questionnaire organization for research and treatment of cancer quality of life questionnaire c-30 (eortc qlq-30). pre-post intervention measure, 3, 6 and 12 months. secondary: cancer-related fatigue evaluated with the functional assessment of scale chronic illness therapy - fatigue (facit-f). pre-post measurement intervention, 3, 6 and 12 months. functional capacity measured with the test 6 minutes walking test. pre-post measurement intervention, 3, 6 and 12 months. valuation of the measured force with manual hydraulic dynamometer and 5- test repetition sit-to-stand. pre-post intervention measure, 3, 6 and 12 months.cost: effectiveness and cost / incremental utility associated to the program wil be estimated.


Eligibility criteria:
inclusion criteria: * age between 18-70 years. * oncological stage i, ii or iii. * completed adjuvant treatment between 3 months to 2 years. ecog 1-2. * sign informed consent exclusion criteria: * inability to read, understand and complete questionnaires, read and understand a brochure explanatory, understand and follow verbal orders (example; illiteracy, dementia or blindness). * musculoskeletal disorders that prevent the exercise of the exercise bike, elliptical, march tape. * important neurological disorders that involve impaired balance, coordination, ataxia. * sporting activity at moderate intensity exceeding 150mnts / week. * symptomatic anemia. * fecal incontinence * patient with a digestive ostomy. * decompensated heart disease, * uncontrolled hypertension * heart failure. * musculoskeletal pathology (except for upper limb pathology in cancer patients of mom) * cardio-respiratory pathology that limits physical activity

Keywords: quality of life terapeutic exercise cancer